IDiyas

For the Inventor, By the Inventor

Redhill, United Kingdom

David Justin Knowles

USPTO Granted Patents = 23

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Surrey RH1 6LY, GB (1998)
  • Redhill, GB (1999 - 2000)
  • Reigate, GB (1999 - 2000)
  • Surrey, GB (2000)
  • Boroughbridge, GB (1999 - 2008)

Company Filing History:

goldMedal30 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 33 
 
Affinium Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1998-2008

Loading Chart...
23 patents (USPTO):Explore Patents
1. 7422749 - Compounds (2008-09-09),
2. 6165989 - Era of Streptococcus pneumoniae (2000-12-26),
3. 6165762 - DNA encoding adenine phosphoribosyltransferase from Streptococcus (2000-12-25),
4. 616576 - DNA encoding adenine phosphoribosyltransferase from Streptococcus (2000-12-26),
5. 6165462 - Sugar kinase (2000-12-26),
6. 6121414 - pcrA protein from Streptococcus pneumoniae (2000-09-19),
7. 6107071 - Histidinol dehydrogenase (2000-08-22),
8. 6054572 - Fibronectin binding protein; monoclonal antibody and their use in (2000-04-25),
9. 6025175 - Glucose kinase from Streptococcus pneumoniae (2000-02-15),
10. 6020159 - 3-dehydroquinate synthase (2000-02-01),
11. 6017728 - ribH (2000-01-25),
12. 6010881 - RibG (2000-01-04),
13. 6008030 - Sugar kinase (1999-12-28),
14. 5965402 - DNA encoding phoH polypeptides (1999-10-12),
15. 5955078 - Fibronectin binding protein polypeptides (1999-09-21),

Title: The Innovations of David Justin Knowles

Introduction: David Justin Knowles, located in Redhill, GB, is a renowned inventor known for his contributions to biotechnology. With an impressive portfolio of 23 patents, Knowles has significantly advanced research in molecular biology and therapeutic applications.

Latest Patents: Among his latest innovations, Knowles has focused on novel compounds derived from Staphylococcal polynucleotides. This invention includes the identification of polypeptides encoded by those polynucleotides and explores their production and therapeutic uses. Another notable patent is related to sugar kinase polypeptides and the methods for producing them through recombinant techniques. This innovation aims to utilize sugar kinase to screen for antibacterial compounds, offering potential avenues for new drug discovery.

Career Highlights: David Justin Knowles has had a dynamic career, working with prominent companies such as SmithKline Beecham Corporation and Affinium Pharmaceuticals, Inc. His experiences in these organizations have provided him with the expertise necessary to push the boundaries of scientific innovation.

Collaborations: Throughout his career, Knowles has collaborated with esteemed professionals in his field, including renowned scientists Michael Terence Black and John Edward Hodgson. These collaborations have significantly enriched his research and development endeavors, leading to groundbreaking inventions and findings.

Conclusion: David Justin Knowles stands out as a leading inventor in the field of biotechnology. Through his extensive patent portfolio and collaborative efforts, he continues to contribute to advancements that hold the promise of enhancing therapeutic options and combating bacterial challenges in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…